Search Results

The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.

• Authors : Amirsadri M; Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Hezar jarib Street, Isfahan, 81746-73461, Iran. .; Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. .

Subjects: Enoxaparin/Enoxaparin/Enoxaparin/*administration & dosage ; Heparin/Heparin/Heparin/*administration & dosage ; Venous Thromboembolism/Venous Thromboembolism/Venous Thromboembolism/*prevention & control

• Source: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences [Daru] 2019 Dec; Vol. 27 (2), pp. 627-634. Date of Electronic Publication: 2019 Jul 31.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101125969 Publication Model: Print-Electronic Cited Medium:

Record details

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.

• Authors : Bikdeli B; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.; Yale/YNHH Center for Outcomes Research and Evaluation, New Haven, Connecticut, United States.

Subjects: SARS-CoV-2* ; COVID-19 Drug Treatment*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage

• Source: Thrombosis and haemostasis [Thromb Haemost] 2022 Jan; Vol. 122 (1), pp. 131-141. Date of Electronic Publication: 2021 Jun 06.Publisher: Thieme Country of Publication: Germany NLM ID: 7608063 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-689X

Record details

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.

• Authors : Sadeghipour P; INSPIRATION Investigators

Subjects: Extracorporeal Membrane Oxygenation*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; COVID-19/COVID-19/COVID-19/*complications

• Source: JAMA [JAMA] 2021 Apr 27; Vol. 325 (16), pp. 1620-1630.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.

• Authors : Bikdeli B; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Yale/YNHH Center for Outcomes Research & Evaluation, New Haven, CT, USA

Subjects: COVID-19 Drug Treatment*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Atorvastatin/Atorvastatin/Atorvastatin/*administration & dosage

• Source: Thrombosis research [Thromb Res] 2020 Dec; Vol. 196, pp. 382-394. Date of Electronic Publication: 2020 Sep 24.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer.

• Authors : Taghizadeh Kermani A; Surgical Oncology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.; Hosseini S

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Enoxaparin/Enoxaparin/Enoxaparin/*therapeutic use ; Esophageal Neoplasms/Esophageal Neoplasms/Esophageal Neoplasms/*drug therapy

• Source: Journal of cellular physiology [J Cell Physiol] 2019 Apr; Vol. 234 (4), pp. 4191-4199. Date of Electronic Publication: 2018 Oct 26.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0050222 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Successful Pregnancy after a Heart Transplant in Iran: A Case Report.

• Authors : Mehri, Fateme^1,2; Saberi, Kianoush³; Salehi, Mehrdad⁴

Subjects: *HEART transplantation; *ENOXAPARIN; *PREDNISOLONEIRAN

• Source: Journal of Tehran University Heart Center. Autumn2023, Vol. 18 Issue 4, p294-297. 4p.

Record details

Data from Shahrekord University of Medical Sciences Provide New Insights into Tissue Transplants (Development of Small-diameter Vascular Grafts Using Pcl/pla/gelatin/ Pva/hyaluronic Acid Nanofibers Containing Vegf/enoxaparin).

• Source: Biotech Week. 2024, pages. 889

Record details

Melatonin-Attenuated Oxidative Stress in High-Risk Pregnant Women Receiving Enoxaparin and Aspirin.

• Authors : Azarmehr, Nahid (AUTHOR); Porhemat, Roghayeh (AUTHOR); Roustaei, Narges (AUTHOR)

Subjects: ENOXAPARIN; SULFUR compounds; C-reactive proteinIRAN

• Source: Evidence-based Complementary & Alternative Medicine (eCAM). 5/25/2023, p1-6. 6p. 1 Chart.

Record details

Comparison of the Effects of Injectable Enoxaparin With Oral Rivaroxaban in Deep Vein Thrombotic Prophylaxis in Patients With Femoral Peritrochanteric Fracture: A Randomized Clinical Trial.

• Authors : Hoseinzadeh, Mosayeb; Bazavar, Mohammad Reza

Subjects: FEMORAL fractures; ENOXAPARIN; CLINICAL trialsIRAN; TABRIZ (Iran)

• Source: Crescent Journal of Medical & Biological Sciences; Jul2022, Vol. 9 Issue 3, p132-137, 6p

Record details

Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.

• Authors : Samimagham, Hamid Reza¹ (AUTHOR); Azad, Mehdi Hassani² (AUTHOR); Hooshyar, Dariush³ (AUTHOR)

Subjects: *ENOXAPARIN; *COVID-19; *MEDICAL personnelIRAN; BANDAR Abbas (Iran)JOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JOHNSON & Johnson (Company) JNJ

• Source: Trials. 7/6/2021, Vol. 22 Issue 1, p1-3. 3p.

Record details